Loading
Latest filing published 03 Jun 2021 for Reviva Pharmaceuticals Holdings, INC., €2.9M.
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
All filings by Vedanta Partners, LLC on record concern Reviva Pharmaceuticals Holdings, Inc. We count 2 filings, every one of them for a trade on 1 June 2021.
On the market, this insider has only ever bought: 2 purchases, €4.1M in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The record was last updated on 3 June 2021 with an open-market purchase (€1.2M) in Reviva Pharmaceuticals Holdings, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration